IMProving Adherence to Colonoscopy Through Teams and Technology

Study acronym: IMPACTT
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Active, Not Recruiting Show 7 more changesShow less
    • Final enrollment: 1418 participants (planned 2000)
    • Primary completion moved earlier from Mar 2027 to Nov 27, 2026
    • Study completion date: Mar 2027 to Feb 28, 2027
    • Secondary endpoints: details revised at 1 of 3 entries
    • Collaborators: 2 to 1
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Recruiting to Enrolling by Invitation
    • Site details revised
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2024 to Jul 8, 2024
    • Site details revised
    v3
  5. Start date: Jan 2024 to Apr 2024v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Complete and timely colonoscopy after an abnormal stool-based colorectal cancer screening test results in early detection, cancer prevention, and reduction in mortality, but follow-up in safety-net health systems occurs in less than 50% at 6 months. The proposal will implement multi-level approach consisting of a stepped-wedge clinic-level intervention of team-based best practices co-developed with primary and specialty care, a patient-level technology intervention to provide enhanced instructions and navigation to complete diagnostic colonoscopy, and a mixed methods evaluation to explore multi-level factors contributing to intervention outcomes. Developing a solution to this high-risk and diverse population has the potential to translate to other health systems, support patient self-management, and address other patient conditions.
Trial Details
NCT Number NCT06191185
Lead Sponsor University of California, San Francisco
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Colon Cancer, Cancer Colorectal, Colorectal Cancer
Related terms Colonic Neoplasms, Colorectal Neoplasms
Enrollment 1,418 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov